Although the underlying mechanism on YAP regulation of NCOA4 require further investigation, targeting YAP using curcumol may become a potential therapeutic strategy for NAFLD. This evidence concerns the gene NCOA4 and metabolic dysfunction-associated steatotic liver disease.